AMPX

Amprius Technologies has seen its stock swing sharply in recent years, which puts a spotlight on a simple question for you as a shareholder or potential buyer: Is the current US$8.88 price tag adequately supported by the sales the business is generating today…

n this NYSE Live interview from the AUSA Annual Meeting & Exposition, Tom Stepien, CEO of Amprius Technologies, discusses advances in battery technology, the company's rapid growth, and the expanding role of drones across defense and commercial markets.

Amprius Technologies CEO Tom Stepien joins J.D. Durkin at AUSA 2026.

Amprius Technologies shares fell after a massive 2024-2026 rally, but a $75 million government grant, analyst price targets as high as $33, and accelerating growth forecasts suggest the correction may be ending.

Amprius Technologies Shelf Registration Sets Up Flexible Funding Options Amprius Technologies (AMPX) has filed an omnibus shelf registration that covers common and preferred stock, debt securities, depositary shares, warrants, subscription rights, purchase…

In late September 2026, Amprius Technologies announced it had entered into a US$75 million fixed-price Other Transaction Agreement with the U.S. Government for Project acCELLerate and secured a separate U.S. Department of War IBAS grant to build secure,…

Amprius Technologies received a $75 million Department of War grant to expand battery manufacturing for drones, easing risk concerns and boosting analyst confidence ahead of its Q3 earnings report.

Amprius Technologies (NYSE:AMPX) shares rose 11% on Monday after the company secured a grant of up to $75 million to retrofit an existing US production line for high-energy-density battery cells.

Investing.com -- Amprius Technologies (NYSE:AMPX) shares rose 11% Monday after the company secured a grant of up to $75 million from the U.S. Department of War to retrofit an existing domestic production line for high-energy density battery cells.